Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients
J. Skrickova, Z. Bortlicek, K. Hejduk, M. Pesek, V. Kolek, L. Koubkova, M. Tomiskova, J. Roubec, L. Havel, F. Salajka, I. Grygarkova, M. Hrnciarik, M. Satankova, Z. Povolna, M. Cernovska, M. Marel, M. Vasakova (Brno, Plzen, Olomouc, Praha, Ostrava, Hradec Kralove, Czech Republic)
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Session: Therapy of thoracic tumours: clinical trials and case series
Session type: Thematic Poster Session
Number: 2721
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Skrickova, Z. Bortlicek, K. Hejduk, M. Pesek, V. Kolek, L. Koubkova, M. Tomiskova, J. Roubec, L. Havel, F. Salajka, I. Grygarkova, M. Hrnciarik, M. Satankova, Z. Povolna, M. Cernovska, M. Marel, M. Vasakova (Brno, Plzen, Olomouc, Praha, Ostrava, Hradec Kralove, Czech Republic). Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients. Eur Respir J 2014; 44: Suppl. 58, 2721
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014
Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
Comorbitities, responses and survival in pts with NSCLC Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
EGFR mutation diagnostic program for NSCLC patients in Poland between 2011-2014 Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015
Survival in lung cancer: Associated factors in Tunisian patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015
Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014
The effect of socioeconomic deprivation on non-small cell lung cancer survival in North East Essex Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014
Lung cancer in England: Trends in survival over the duration of the national lung cancer audit Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013
Integrative analysis of DNA copy number in metastatic NSCLC identifies drug sensitivity to Afatinib Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014
Epidemiological changes of patients with lung cancer over Years Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013
Lung cancer in women: A seven years study in Eastern Algeria Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015